How a Global Top-3 Diagnostics Leader scaled sample access with Boca Bio

This case study highlights how a global top-three diagnostics company successfully scaled biospecimen access by partnering with Boca Bio. Facing challenges with inconsistent sample quality, delays, and limited access to rare disease specimens, the company needed a reliable solution to support assay development and regulatory submissions. Boca Bio leveraged its global biorepository and clinical network to rapidly deliver high-quality, well-characterized samples at scale, enabling consistent data generation and faster study progression. The partnership improved operational efficiency, reduced costs, and accelerated diagnostic development timelines.